论文部分内容阅读
目的观察银杏达莫、洛伐他汀联合治疗急性脑梗塞的临床疗效。方法选取我院2013年9月至2016年9月收治的101例急性脑梗死患者的临床资料,根据治疗方案的不同将其分为两组,其中单纯行银杏达莫的47例设为对照组,联合洛伐他汀治疗的54例设为研究组,比较两组治疗前后神经功能改善及安全性。结果两组治疗后DNS评分较治疗前均显著下降,且研究组下降幅度较之对照组显著更大(P<0.05);研究组各血脂指标水平较之对照组均更低(P<0.05)。结论急性脑梗塞行联合用药方案可有效改善患者神经功能,且降低血脂水平,具临床应用价值。
Objective To observe the clinical efficacy of gingko-damo and lovastatin in the treatment of acute cerebral infarction. Methods The clinical data of 101 patients with acute cerebral infarction who were admitted to our hospital from September 2013 to September 2016 were selected and divided into two groups according to the different treatment regimens. Among them, 47 patients with simplex ginkgo-di-mo were treated as control group , Combined lovastatin treatment of 54 cases as the study group, compared two groups before and after treatment to improve neurological function and safety. Results The DNS scores of both groups decreased significantly after treatment compared with those before treatment, and the decline rate of the study group was significantly greater than that of the control group (P <0.05). The levels of serum lipid in the study group were lower than those of the control group (P <0.05) . Conclusion Acute cerebral infarction combined with medication can effectively improve the patient’s neurological function, and reduce blood lipid levels, with clinical value.